Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.07 | 1.68 |
NAV | ₹21.97 | ₹208.03 |
Fund Started | 15 Nov 2019 | 20 Aug 2004 |
Fund Size | ₹1739.42 Cr | ₹15687.54 Cr |
Exit Load | For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days. | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 7.41% | 18.39% |
3 Year | 12.85% | 21.91% |
5 Year | 16.75% | 22.57% |
1 Year
3 Year
5 Year
Equity | 97.38% | 83.94% |
Cash | 2.62% | 15.74% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.65% |
Tech Mahindra Ltd. | 8.45% |
Zomato Ltd. | 6.55% |
KEC International Ltd. | 5.23% |
Axis Bank Ltd. | 5.11% |
ICICI Bank Ltd. | 4.86% |
Firstsource Solutions Ltd. | 3.97% |
Amber Enterprises India Ltd. | 3.87% |
Reliance Industries Ltd. | 3.62% |
Alkem Laboratories Ltd. | 3.19% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.18% |
HDFC Bank Ltd. | 8.88% |
Axis Bank Ltd. | 8.49% |
Maruti Suzuki India Ltd. | 4.90% |
SBI Life Insurance Company Ltd. | 4.26% |
Kotak Mahindra Bank Ltd. | 4.24% |
Cipla Ltd. | 3.96% |
Bharti Airtel Ltd. | 3.63% |
HCL Technologies Ltd. | 3.41% |
Piramal Pharma Ltd. | 3.12% |
Name | Arvindkumar Kumaresan Chetty | Dhruv Muchhal |
Start Date | 01 Dec 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 15 Nov 2019 | 20 Aug 2004 |
Description
Launch Date